Authors/Disclosures
|
David S. Knopman, MD, FAAN
(Mayo Clinic)
|
Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
|
Vimala S. Vajjala, MBBS
(Insomnia and Sleep Institute of Arizona)
|
Dr. Vajjala has nothing to disclose. |
|
Diederik L. Koelman
|
No disclosure on file |
|
Thomas H. Mosley, PhD
(University of Misssissippi Medical Center)
|
No disclosure on file |
|
Sandhya Mehla, MD
(Hartford Healthcare Headache center)
|
Dr. Mehla has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Yan Xu
|
Yan Xu has nothing to disclose. |
|
|
No disclosure on file |
|
Xiumin Shermyn Neo, MD
(National Neuroscience Institute)
|
No disclosure on file |
|
Maria M. Shiung, BA
(Mayo Clinic)
|
No disclosure on file |
|
Kevin Tan, MD, FAAN
(National Neuroscience Institute)
|
Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Gen Sobue, MD
(Nagoya University School Of Medicine/Dept. of Neurology)
|
Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nippon Chemiphar Co., Ltd.. Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Takeda Pharmaceutical Company Limited.. |
|
|
No disclosure on file |
|
Jun Natsume, MD, PhD
(Department of Pediatrics)
|
No disclosure on file |
|
Salim Chahin, MD
(Washington University School of Medicine, Neurology Dept.)
|
Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutic . The institution of Dr. Chahin has received research support from National MS Society. The institution of Dr. Chahin has received research support from BMS. |
|
Soe S. Mar, MD, FAAN
(Washington University School of Medicine)
|
The institution of Dr. Mar has received research support from NIH. |
|
Arun Venkatesan, MD, PhD
(Johns Hopkins Hospital)
|
Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from MSRCF. The institution of Dr. Venkatesan has received research support from U.S. DOD. |
|
Tanuja Chitnis, MD, FAAN
(Brigham and Women's Hospital)
|
Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover. |
|
|
No disclosure on file |
|
Anusha Yeshokumar, MD
(Icahn School of Medicine at Mount Sinai)
|
Dr. Yeshokumar has nothing to disclose. |
|
Paula Barreras, MD
(Cedars-Sinai Medical Center)
|
The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from 好色先生. |
|
Bittu Majmudar-Sheth, MD
(Pediatric Neurology, Riley Children's Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
Farrah J. Mateen, MD, PhD, FAAN
(Massachusetts General Hospital)
|
Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics (Amgen). Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from EMD Serono. The institution of Dr. Mateen has received research support from Novartis. The institution of Dr. Mateen has received research support from Horizon Therapeutics (Amgen). The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |